Te Ahumairangi Investment Management Ltd boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 14.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 127,106 shares of the real estate investment trust's stock after acquiring an additional 15,800 shares during the period. Te Ahumairangi Investment Management Ltd owned 0.05% of Sabra Healthcare REIT worth $2,221,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the business. Allspring Global Investments Holdings LLC purchased a new stake in shares of Sabra Healthcare REIT during the first quarter valued at $298,000. New York State Teachers Retirement System lifted its position in shares of Sabra Healthcare REIT by 12.1% during the 1st quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock valued at $5,619,000 after buying an additional 34,591 shares in the last quarter. M&T Bank Corp raised its stake in Sabra Healthcare REIT by 2.1% in the 1st quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock valued at $905,000 after purchasing an additional 1,059 shares during the last quarter. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Sabra Healthcare REIT by 4.7% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock worth $331,000 after purchasing an additional 853 shares during the period. Finally, Ethos Financial Group LLC purchased a new position in Sabra Healthcare REIT during the 1st quarter valued at about $1,150,000. Institutional investors own 99.40% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have commented on SBRA. BMO Capital Markets boosted their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. Wells Fargo & Company raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 27th. JMP Securities raised their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a report on Wednesday, August 6th. Finally, Scotiabank increased their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT presently has an average rating of "Moderate Buy" and an average price target of $20.43.
Check Out Our Latest Stock Report on Sabra Healthcare REIT
Sabra Healthcare REIT Trading Up 0.8%
SBRA stock traded up $0.15 during trading on Tuesday, reaching $19.26. The company had a trading volume of 2,260,454 shares, compared to its average volume of 2,460,082. Sabra Healthcare REIT, Inc. has a 52 week low of $15.60 and a 52 week high of $20.03. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The business has a 50 day moving average of $18.57 and a 200 day moving average of $17.82. The company has a market cap of $4.62 billion, a P/E ratio of 25.34, a PEG ratio of 1.52 and a beta of 0.88.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period in the previous year, the firm posted $0.36 EPS. Sabra Healthcare REIT's revenue for the quarter was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.2%. Sabra Healthcare REIT's dividend payout ratio (DPR) is 157.89%.
About Sabra Healthcare REIT
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Articles

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.